Creagri, Inc. v. Pinnaclife Inc

Filing 46

ORDER by Judge Lucy H. Koh granting in part and denying in part 27 Motion to Dismiss (lhklc2, COURT STAFF) (Filed on 1/1/2013)

Download PDF
1 2 3 4 5 6 7 UNITED STATES DISTRICT COURT 8 NORTHERN DISTRICT OF CALIFORNIA 9 SAN JOSE DIVISION United States District Court For the Northern District of California 10 CREAGRI, INC., a California Corporation, 11 12 13 Plaintiff, v. PINNACLIFE INC., a Nevada Corporation, 14 Defendant. 15 16 ) ) ) ) ) ) ) ) ) ) Case No.: 5:11-CV-06635-LHK ORDER DENYING IN PART AND GRANTING IN PART DEFENDANT’S MOTION TO DISMISS Plaintiff CreAgri, Inc. (“CreAgri”) filed this action against Pinnaclife, Inc. (“Pinnaclife”) 17 on December 23, 2011, alleging infringement of U.S. Patent No. 6,416,808 (“the ’808 Patent”). 18 ECF No. 1. On July 30, 2012, CreAgri filed an amended complaint, which included the addition of 19 claims for direct and indirect infringement of U.S. Patent No. 8,216,599 (“the ’599 Patent”). ECF 20 No. 23. Now before the Court is Pinnaclife’s motion to dismiss Count II of the Amended 21 Complaint (“AC”). ECF No. 27 (“Mot.”). CreAgri filed an opposition, ECF No. 30, and 22 Pinnaclife filed a reply. ECF No. 33. Having reviewed the parties’ pleadings and the relevant law, 23 the Court finds this matter appropriate for resolution without oral argument pursuant to Civil Local 24 Rule 7-1(b). Accordingly, the hearing on these motions set for January 3, 2012 is VACATED. 25 However, the Case Management Conference remains as set on January 3, 2013 at 1:30 p.m. For 26 the reasons discussed below, the Court DENIES in part and GRANTS in part Pinnaclife’s motion 27 to dismiss with leave to amend. 28 I. Background 1 Case No.: 5:11-CV-06635-LHK ORDER DENYING IN PART AND GRANTING IN PART DEFENDANT’S MOTION TO DISMISS 1 CreAgri makes and sells products containing olive derived polyphenols intended to promote health. AC at ¶¶ 7-9. On July 9, 2002, the ’808 Patent, entitled “Method Of Obtaining A 3 Hydroxytyrosol-rich Composition From Vegetation Water,” was issued to CreAgri. AC at ¶ 11 & 4 Exh. A. Pinnaclife makes a range of dietary supplement products also relating to olives, including 5 miracle Olivamine10 Essential, miracle Olivamine10 Full Spectrum, miracle Olivamine 10 Omega-3, 6 miracle Olivamine 10 Mineral Boost, and miracle Olivamine 10 Cleanse. Id. at ¶ 19. On December 7 23, 2011, CreAgri filed this suit against Pinnaclife, alleging that Pinnaclife infringes the ’808 8 Patent by making, using, selling, offering for sale, and/or importing these and other products. 9 Pinnaclife filed an Answer on February 13, 2012, ECF No. 8, denying that Pinnaclife infringes the 10 United States District Court For the Northern District of California 2 ’808 Patent, and raising several affirmative defenses and counterclaims. CreAgri filed an answer 11 to the counterclaims on March 5, 2012. ECF No. 11. 12 Subsequently, on July 10, 2012, the ’599 Patent, entitled “Method For Treatment of 13 Inflammation,” was issued to CreAgri. Id. at ¶ 15 & Exh. B. CreAgri then filed the AC to add a 14 second count for direct and indirect infringement of this new patent (“Count II”). Pinnaclife moves 15 to dismiss Count II for failure to meet the pleading requirements for direct and indirect patent 16 infringement. 17 18 II. Legal Standard A motion to dismiss pursuant to Rule 12(b)(6) for failure to state a claim upon which relief 19 can be granted “tests the legal sufficiency of a claim.” Navarro v. Block, 250 F.3d 729, 732 (9th 20 Cir. 2001). Under Federal Rule of Civil Procedure 8, a Complaint must “give the defendant fair 21 notice of what the . . . claim is and the grounds upon which it rests.” Bell Atl. Corp. v. Twombly, 22 550 U.S. 544, 555 (2007) (quoting Conley v. Gibson, 355 U.S. 41, 47 (1957)). While “‘detailed 23 factual allegations’” are not required, a complaint must include sufficient facts to “‘state a claim to 24 relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Twombly, 25 550 U.S. at 555, 570). “A claim has facial plausibility when the plaintiff pleads factual content that 26 allows the court to draw the reasonable inference that the defendant is liable for the misconduct 27 alleged.” Id. 28 2 Case No.: 5:11-CV-06635-LHK ORDER DENYING IN PART AND GRANTING IN PART DEFENDANT’S MOTION TO DISMISS 1 The sufficiency of a complaint for direct patent infringement, however, is governed by a 2 different standard. Such a complaint “is to be measured by the specificity required by Form 18” in 3 the Appendix of Forms to the Federal Rules of Civil Procedure. In re Bill of Lading Transmission 4 and Processing System Patent Litigation, 681 F.3d 1323, 1334 (Fed. Cir. 2012). In this context, 5 the Twombly and Iqbal standard is “too stringent.” Id. at 1335. This exception to the specificity 6 requirements of Twombly and Iqbal applies only to claims of direct patent infringement, not to 7 claims of indirect infringement. Id. at 1336-37 (“Form 18 should be strictly construed as 8 measuring only the sufficiency of allegations of direct infringement, and not indirect 9 infringement.”). A claim for indirect infringement must instead satisfy the specific requirements United States District Court For the Northern District of California 10 articulated in Twombly and Iqbal. Id. For purposes of ruling on a Rule 12(b)(6) motion to dismiss, 11 the Court accepts all allegations of material fact as true and construes the pleadings in the light 12 most favorable to the plaintiff. Manzarek v. St. Paul Fire & Marine Ins. Co., 519 F.3d 1025, 1031 13 (9th Cir. 2008). 14 If a court grants a motion to dismiss, leave to amend should be granted unless the pleading 15 could not possibly be cured by the allegation of other facts. Lopez v. Smith, 203 F.3d 1122, 1130 16 (9th Cir. 2000). A court “may exercise its discretion to deny leave to amend due to ‘undue delay, 17 bad faith or dilatory motive on part of the movant, repeated failure to cure deficiencies by 18 amendments previously allowed, undue prejudice to the opposing party . . . [and] futility of 19 amendment.’” Carvalho v. Equifax Info. Servs., LLC, 629 F.3d 876, 892-93 (9th Cir. 2010) 20 (quoting Foman v. Davis, 371 U.S. 178, 182 (1962)); see also Abagninin v. AMVAC Chem. Corp., 21 545 F.3d 733, 742 (9th Cir. 2008) (repeated failure to cure deficiencies by previous amendment 22 sufficient to deny leave to amend). 23 III. Discussion 24 A. Direct Infringement 25 The ’599 Patent consists of method claims. It is well established that a patent claiming a 26 method is not infringed “unless all steps or stages of the claimed process are utilized.” NTP, Inc. v. 27 Research in Motion, Ltd.,418 F.3d 1282, 1317 (Fed. Cir. 2005). However, a claim for direct 28 infringement of a method patent is still a claim for direct infringement, and is therefore governed 3 Case No.: 5:11-CV-06635-LHK ORDER DENYING IN PART AND GRANTING IN PART DEFENDANT’S MOTION TO DISMISS 1 by the Form 18 pleading standard. Nothing in Form 18 suggests that its applicability is limited to 2 device patents, nor did the Federal Circuit, in confirming that pleading requirements for direct 3 infringement claims are governed by Form 18, suggest that this holding should be limited to device 4 patents. Indeed, Pinnaclife appears to agree that CreAgri need only meet Form 18’s pleading 5 requirements to state a claim for direct infringement. See Mot. at 3. 6 Instead, Pinnaclife argues that CreAgri’s factual allegations are insufficient to meet even 7 this low standard. CreAgri has alleged that Pinnaclife infringed the ’599 Patent “literally or under 8 the doctrine of equivalents, by making, using, importing, offering to sell and/or selling products 9 which infringe the ’599 Patent, including but not limited to, miracle Olivamine10 Essential.” AC at United States District Court For the Northern District of California 10 ¶ 32. Pinnaclife argues that CreAgri has not alleged the actual performance of the steps of the 11 patented method. Mot. at 4. But using a product, which CreAgri has alleged, could certainly entail 12 the performance of a patented method. See, e.g., Lucent Technologies, Inc. v. Gateway, Inc., 580 13 F.3d 1301, 1318 (Fed. Cir. 2009) (affirming jury’s finding of infringement of method patent by use 14 of products). Moreover, CreAgri’s allegation precisely tracks the language of Form 18. Form 18 15 does not require a plaintiff to identify all of the claim limitations and how they are infringed for a 16 device patent, nor does it require a plaintiff to list all of the steps for a method patent. Instead, 17 Form 18 requires a simple allegation that the defendant has infringed “by making, selling, and 18 using” the patented article. That is precisely what CreAgri has provided here. Pinnaclife has 19 presented no other reason why CreAgri’s claim for direct infringement is insufficient. 20 Accordingly, Pinnaclife’s motion to dismiss CreAgri’s claim for direct infringement of the ’599 21 Patent is DENIED. 22 23 B. Indirect Infringement Count II also alleges indirect infringement, both by inducement and by contributory 24 infringement of the ’599 Patent. Indirect patent infringement, either by inducement or by 25 contributory infringement, requires an allegation of direct infringement by another. Dynacore 26 Holdings Corp. v. U.S. Philips Corp., 363 F.3d 1263, 1274 (Fed. Cir. 2004). The direct 27 infringement requirement can be satisfied in the inducement context by proving that the 28 defendant’s products necessarily infringe. See Lucent Technologies, 580 F.3d at 1322 (“[A] 4 Case No.: 5:11-CV-06635-LHK ORDER DENYING IN PART AND GRANTING IN PART DEFENDANT’S MOTION TO DISMISS 1 finding of inducement requires a threshold finding of direct infringement-either a finding of 2 specific instances of direct infringement or a finding that the accused products necessarily 3 infringe.”) (internal citations and quotation marks omitted). 4 Regarding inducement, 35 U.S.C. § 271(b) provides that “Whoever actively induces 5 infringement of a patent shall be liable as an infringer.” Inducement requires proof not only of 6 infringement by another, but that the defendant “possessed the requisite knowledge or intent to be 7 held vicariously liable.” Dynacore Holdings, 363 F.3d at 1273 (internal citations omitted). To 8 survive a motion to dismiss, a plaintiff must plead “facts plausibly showing that the [defendant] 9 specifically intended their customers to infringe the [patent].” Bill of Lading, 681 F.3d at 1339. United States District Court For the Northern District of California 10 Contributory infringement refers to the “core notion that one who sells a component 11 especially designed for use in a patented invention may be liable as a contributory infringer, 12 provided that the component is not a staple article of commerce suitable for substantial 13 noninfringing use.” Ricoh Co., Ltd. v. Quanta Computer Inc., 550 F.3d 1325, 1337 (Fed. Cir. 14 2008). “In order to succeed on a claim of contributory infringement, in addition to proving an act 15 of direct infringement, plaintiff must show that defendant knew that the combination for which its 16 components were especially made was both patented and infringing’ and that defendant’s 17 components have no substantial non-infringing uses.” Lucent Technologies, 580 F.3d at 1320 18 (internal citations and quotation marks omitted). 19 Here, CreAgri has not alleged that anyone other than Pinnaclife has directly infringed the 20 ’599 Patent, nor has CreAgri alleged that any Pinnaclife product necessarily infringes the ’599 21 Patent. CreAgri does allege that “Pinnaclife publishes and provides documents intending that 22 persons including the manufacturers, sellers, resellers, distributors, users and customers engage in 23 direct infringement by their use of Pinnaclife’s ‘miracle Olivamine10 Essential,’” FAC at ¶ 33, but 24 there is no allegation that any of these third parties has actually directly infringed, nor that use of 25 any Pinnaclife product necessarily infringes. Rule 8 requires that a complaint, including one 26 alleging claims for indirect infringement, “must contain sufficient factual matter, accepted as true, 27 to ‘state a claim to relief that is plausible on its face.’” Iqbal, 556 U.S. at 678 (quoting Twombly, 28 550 U.S. at 570). Thus, to satisfy Rule 8 in the context of a claim for indirect infringement, a 5 Case No.: 5:11-CV-06635-LHK ORDER DENYING IN PART AND GRANTING IN PART DEFENDANT’S MOTION TO DISMISS 1 plaintiff would, at a minimum, have to identify who allegedly directly infringed and how, or would 2 have to allege that use of some particular product necessarily infringed. If CreAgri had made such 3 allegations, the Court would accept them as true at this stage. But without such allegations, 4 CreAgri has not alleged facts sufficient to establish that Pinnaclife has induced, or contributed to, 5 any infringement. Accordingly, CreAgri has failed to state a claim for indirect infringement on 6 which relief can be granted. 7 Moreover, CreAgri must provide more specificity regarding the documents alleged to have 8 induced infringement. The AC says only that Pinnaclife “publishes and provides documents 9 intending that persons including the manufacturers, sellers, resellers, distributors, users, and United States District Court For the Northern District of California 10 customers engage in direct infringement by their use of Pinnaclife’s ‘miracle Olivamine10 11 Essential.” AC at ¶ 34. Although CreAgri need not provide a detailed description of the 12 documents, CreAgri must provide enough information to give Pinnaclife “fair notice of what the ... 13 claim is and the grounds upon which it rests.” Iqbal, 556 U.S. at 698-99, quoting Twombly, 550 14 U.S., at 555 (omission in original). The claim for indirect infringement, as currently pleaded, does 15 not provide the required notice. Further, CreAgri has not alleged any facts supporting an inference 16 of intent to induce infringement. “In assessing whether it is reasonable to infer intent from 17 statements or conduct . . . the Supreme Court recently made clear that a court must assess the facts 18 in the context in which they occurred and from the standpoint of the speakers and listeners within 19 that context.” Bill of Lading, 681 F.3dat 1340 (citing Matrixx Initiatives, Inc. v. Siracusano, 131 20 S.Ct. 1309, 1324 (2011). Here, however, the conclusory statement that that Pinnaclife publishes 21 documents “intending” that persons infringe, AC at ¶ 35, does not provide any facts at all from 22 which such an inference could be drawn. Thus, CreAgri has not sufficiently pleaded its claim for 23 induced infringement. 24 C. Leave to Amend 25 The dismissal of the indirect infringement claim of Count II of the AC is due to a 26 deficiency in pleading, not necessarily a deficiency in legal theory. CreAgri may be able to cure 27 this deficiency by the allegation of additional facts. Accordingly, the Court grants CreAgri leave to 28 amend its complaint. 6 Case No.: 5:11-CV-06635-LHK ORDER DENYING IN PART AND GRANTING IN PART DEFENDANT’S MOTION TO DISMISS 1 2 IV. Conclusion For the foregoing reasons, CreAgri’s motion to dismiss Count II of the AC is DENIED in 3 part and GRANTED in part with leave to amend. An amended complaint, if any, must be filed 4 within 21 days of the date of this Order. CreAgri may not add new claims or parties without 5 seeking the opposing party’s consent or leave of the Court pursuant to Federal Rule of Civil 6 Procedure 15. Failure to cure the deficiencies identified herein or to timely file an amended 7 complaint will result in dismissal of the indirect infringement claim in Count II with prejudice. 8 IT IS SO ORDERED. 9 Dated: January 1, 2013 United States District Court For the Northern District of California 10 _________________________________ LUCY H. KOH United States District Judge 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 7 Case No.: 5:11-CV-06635-LHK ORDER DENYING IN PART AND GRANTING IN PART DEFENDANT’S MOTION TO DISMISS

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?